WebDec 1, 2024 · The ongoing multi-center Renal Anhydramnios Fetal Therapy (RAFT) trial is assessing the safety and efficacy of serial amnioinfusions to prevent pulmonary … WebUnilateral renal agenesis is an autosomal dominant disease. This means a child will develop the disease if they inherit a copy of the changed gene from one parent. Often, the parent …

RAFT – Renal Anhydramnios Fetal Therapy Trial

WebRenal Agenesis Fetal Therapy (RAFT) Trial (NAFTNet) Principal Investigator: Yair Blumenfeld, MD The goal of this research is to determine the feasibility, safety and success rate of serial amnioinfusions for early pregnancy renal anhydramnios caused by congenital bilateral renal agenesis and by fetal renal failure with kidney tissue present. WebMar 27, 2024 · The Renal Anhydramnios Fetal Therapy (RAFT) Trial offers eligible pregnant women with a diagnosis of EPRA an experimental therapy of repeated or serial "amnioinfusions" of fluid into the womb. An amnioinfusion involves placing a small needle through the pregnant woman's skin into the womb next to the fetus. Warm sterile fluid … bluetooth ignorieren aufheben iphone

Fetal Therapy for Renal Anhydramnios - PubMed

WebUpdate: Due to recommendations from the RAFT trial Data and Safety Monitoring Board, the trial is no longer open to enrollment for pregnancies complicated by bilateral renal agenesis as of July 19, 2024. Enrollment for patients with pregnancies complicated by other causes of fetal renal failure remains open. Official Title WebRestoring amniotic fluid around the fetus is the principal goal of prenatal treatment. The ongoing multi-center Renal Anhydramnios Fetal Therapy (RAFT) trial is assessing the safety and efficacy of serial amnioinfusions to prevent pulmonary hypoplasia so that the underlying renal disease can be addressed. Keywords: WebIn the RAFT trial, EPRA has been divided into two groups to be stud-ied independently in terms of response to serial amnioinfusions. The first is the congenital bilateral renal … clear white phlegm throat